Publications by authors named "Julie Agopian"

Claim this Profile
C
Characteristics and Therapeutic Strategies for Diffuse Cutaneous Mastocytosis.
Paula Pernea, Cecile Méni, Julien Rossignol, Hélène Aubert, Sébastien Barbarot, Julie Agopian

JAMA Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.
Julien Rossignol, Sophie Georgin-Lavialle, Danielle Canioni, Omer Beganovic, Chantal Brouzes, Julie Agopian

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
Maël Heiblig, Clément Gourguechon, Philippe Guilpain, Cristina Bulai-Livideanu, Stéphane Barete, Julie Agopian

Am J Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological characterization of liver involvement in systemic mastocytosis.
Julien Rossignol, Danielle Canioni, Achille Aouba, Cristina Bulai-Livideanu, Stéphane Barete, Julie Agopian

Liver Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study.
Josquin Moraly, Julien Rossignol, Claire Rouzaud, Thomas Gabas, Hassiba Bouktit, Julie Agopian

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
Laura Polivka, Marine Madrange, Cristina Bulai-Livideanu, Stéphane Barete, Thomas Ballul, Julie Agopian

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond.
Susan V Jennings, Celeste C Finnerty, Jessica S Hobart, Mercedes Martín-Martínez, Kristin A Sinclair, Julie Agopian

J Allergy Clin Immunol Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders.
Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, Stéphane Barete, Louis Terriou, Julie Agopian

J Allergy Clin Immunol Pract· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET2 regulates immune tolerance in chronically activated mast cells.
Riccardo Rigo, Rabie Chelbi, Julie Agopian, Sebastien Letard, Aurélien Griffon

JCI Insight· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing diagnostic criteria for mastocytosis in skin biopsies.
Philippe Drabent, Laura Polivka, Julie Agopian, Jean-Paul Duong Van Huyen, Pierre-Alain Thiebaut

Histopathology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness.
Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano, Paraskevi Kousteridou

Blood· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-Up.
Laura Polivka, Julien Rossignol, Antoine Neuraz, Djiba Condé, Julie Agopian

J Allergy Clin Immunol Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.
Olivier Lortholary, Marie Olivia Chandesris, Cristina Bulai Livideanu, Carle Paul, Gérard Guillet, Julie Agopian

Lancet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report.
Jarmila Prosvicova, Sarka Lukesova, Jindrich Kopecky, Jiri Grim, Zdenek Papik, Julie Agopian

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
Marina Vita, Julie C Tisserand, Isaure Chauvot de Beauchêne, Nicolas Panel, Luba Tchertanov, Julie Agopian

JAMA Dermatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes.
Katia Hanssens, Fabienne Brenet, Julie Agopian, Sophie Georgin-Lavialle, Gandhi Damaj

Haematologica· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agricultural pesticide exposure and the molecular connection to lymphomagenesis.
Julie Agopian, Jean-Marc Navarro, Anne-Claire Gac, Yannick Lecluse, Mélanie Briand

J Exp Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis.
Sandrine Roulland, Jean-Marc Navarro, Pierre Grenot, Michèle Milili, Julie Agopian

J Exp Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis